Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer - Scorecard - MDSpire
Advertisement
Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer
Clinical Scorecard: Identification of an Oxidative Phosphorylation Profile through Machine Learning for Prognostic Assessment, Immune Cell Infiltration, and Drug Response in Ovarian Cancer
At a Glance
Category
Detail
Condition
Ovarian Cancer
Key Mechanisms
Oxidative phosphorylation (OXPHOS) pathway and its related gene signature (OPRGS)
Target Population
Patients diagnosed with ovarian cancer
Care Setting
Oncology clinics and research settings
Key Highlights
OXPHOS identified as a core metabolic pathway in ovarian cancer.
High-risk scores correlate with immunosuppressive tumor microenvironment.
OPRGS associated with chemotherapy resistance to paclitaxel but sensitivity to carboplatin.
KIF1A identified as a key gene for further investigation in OC.
Study utilizes multiple datasets for robust pathway identification.
Guideline-Based Recommendations
Diagnosis
Utilize gene set enrichment analysis (GSEA) for metabolic pathway identification.
Management
Consider OPRGS for predicting prognosis and chemotherapy sensitivity.
Monitoring & Follow-up
Monitor immune cell infiltration and tumor microenvironment characteristics.
Risks
High OPRGS may indicate resistance to certain chemotherapy agents.
Patient & Prescribing Data
Ovarian cancer patients with varying tumor subtypes and stages.
Sensitivity to carboplatin and resistance to paclitaxel based on OPRGS.
Clinical Best Practices
Integrate multi-dataset analysis for robust biomarker identification.
Utilize machine learning models for prognostic assessment.
